Much rests on metformin’s shoulders: as the first drug to begin clinical trials for preventing multiple age-related diseases, it could soon become the...
Metformin: Can you have your cake and eat it, too?
When Americans 50 years ago envisioned the perfect youthful physique, the trim, athletic body would surely have sported a sun-baked complexion. And wh...
Rapamycin: An impressive geroprotector with a few potential flaws
If any drug has performed consistently and unequivocally well in anti-aging trials, it’s rapamycin. Dr. Matt Kaeberlein’s Dog Aging Project is among t...
Best friends forever: Matt Kaeberlein on helping dogs live longer
Dr. Matt Kaeberlein, an aging researcher and professor at the University of Washington, is the director of the Dog Aging Project. This two part progra...
Intriguing results for Thioflavin T, but reproducibility is the real winner in CITP
Bolstering results from a 2011 study, a team led by Buck Institute researcher Gordon Lithgow found the compound Thioflavin T to increase the lifespan ...